Catalyst Offers Strategic Regulatory Insights on Moving Innovations Forward at FDA During Biotech Showcase Conference
During an interactive workshop on the evolving FDA, Catalyst President Nancy Bradish Myers explored some of the challenges faced by drug and device companies in getting new, cutting edge technologies through the FDA most appropriately and efficiently. Leaders at the agency "really are trying to deal with this innovation concept, and trying not to be a